Search Results - "Sarparanta, Mirkka"

Refine Results
  1. 1

    Multimodality Imaging of Silica and Silicon Materials In Vivo by Karaman, Didem Şen, Sarparanta, Mirkka P., Rosenholm, Jessica M., Airaksinen, Anu J.

    Published in Advanced materials (Weinheim) (01-06-2018)
    “…Recent progress in the development of silica‐ and silicon‐based multimodality imaging nanoprobes has advanced their use in image‐guided drug delivery, and the…”
    Get full text
    Journal Article
  2. 2

    Harnessing PET to track micro- and nanoplastics in vivo by Keinänen, Outi, Dayts, Eric J., Rodriguez, Cindy, Sarrett, Samantha M., Brennan, James M., Sarparanta, Mirkka, Zeglis, Brian M.

    Published in Scientific reports (01-06-2021)
    “…The proliferation of plastics in the environment continues at an alarming rate. Plastic particles have been found to be persistent and ubiquitous pollutants in…”
    Get full text
    Journal Article
  3. 3

    Multifunctional porous silicon nanoparticles for cancer theranostics by Wang, Chang-Fang, Sarparanta, Mirkka P, Mäkilä, Ermei M, Hyvönen, Maija L.K, Laakkonen, Pirjo M, Salonen, Jarno J, Hirvonen, Jouni T, Airaksinen, Anu J, Santos, Hélder A

    Published in Biomaterials (01-04-2015)
    “…Abstract Nanomaterials provide a unique platform for the development of theranostic systems that combine diagnostic imaging modalities with a therapeutic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives by Matović, Jelena, Järvinen, Juulia, Sokka, Iris K, Imlimthan, Surachet, Aitio, Olli, Sarparanta, Mirkka, Rautio, Jarkko, Ekholm, Filip S

    Published in Molecules (Basel, Switzerland) (09-09-2024)
    “…Boron Neutron Capture Therapy (BNCT) is a cancer treatment which combines tumor-selective boron delivery agents with thermal neutrons in order to selectively…”
    Get full text
    Journal Article
  6. 6

    Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake by Wang, Chang-Fang, Mäkilä, Ermei M, Kaasalainen, Martti H, Liu, Dongfei, Sarparanta, Mirkka P, Airaksinen, Anu J, Salonen, Jarno J, Hirvonen, Jouni T, Santos, Hélder A

    Published in Biomaterials (01-01-2014)
    “…Abstract Porous silicon (PSi) has been demonstrated as a promising drug delivery vector for poorly water-soluble drugs. Here, a simple and efficient method…”
    Get full text
    Journal Article
  7. 7

    Evaluation of Organo [ 18 F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers by Otaru, Sofia, Imlimthan, Surachet, Sarparanta, Mirkka, Helariutta, Kerttuli, Wähälä, Kristiina, Airaksinen, Anu J

    Published in Molecules (Basel, Switzerland) (07-03-2020)
    “…Fluorine-18 is the most widely used positron emission tomography (PET) radionuclide currently in clinical application, due to its optimal nuclear properties…”
    Get full text
    Journal Article
  8. 8

    The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems by Sarparanta, Mirkka P, Bimbo, Luis M, Mäkilä, Ermei M, Salonen, Jarno J, Laaksonen, Päivi H, Helariutta, A.M. Kerttuli, Linder, Markus B, Hirvonen, Jouni T, Laaksonen, Timo J, Santos, Hélder A, Airaksinen, Anu J

    Published in Biomaterials (01-04-2012)
    “…Abstract Impediments to intestinal absorption, such as poor solubility and instability in the variable conditions of the gastrointestinal (GI) tract plague…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction by Wang, Shiqi, Shcherbii, Mariia V., Hirvonen, Sami-Pekka, Silvennoinen, Gudrun, Sarparanta, Mirkka, Santos, Hélder A.

    Published in Communications chemistry (15-08-2024)
    “…Efficient intracellular delivery is crucial for biotherapeutics, such as proteins, oligonucleotides, and CRISPR/Cas9 gene-editing systems, to achieve their…”
    Get full text
    Journal Article
  11. 11

    Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles by Keinänen, Outi, Mäkilä, Ermei M., Lindgren, Rici, Virtanen, Helena, Liljenbäck, Heidi, Oikonen, Vesa, Sarparanta, Mirkka, Molthoff, Carla, Windhorst, Albert D., Roivainen, Anne, Salonen, Jarno J., Airaksinen, Anu J.

    Published in ACS omega (31-01-2017)
    “…Pretargeted positron emission tomography (PET) imaging based on bioorthogonal chemical reactions has proven its potential in immunoimaging. It may also have…”
    Get full text
    Journal Article
  12. 12

    In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging by Kallinen, Annukka M, Sarparanta, Mirkka P, Liu, Dongfei, Mäkilä, Ermei M, Salonen, Jarno J, Hirvonen, Jouni T, Santos, Hélder A, Airaksinen, Anu J

    Published in Molecular pharmaceutics (04-08-2014)
    “…The use of nanoparticle carriers for the sustained release of cytotoxic drugs in cancer therapy can result in fewer adverse effects and can thus be of great…”
    Get full text
    Journal Article
  13. 13

    SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I by Rajecki, Maria, Sarparanta, Mirkka, Hakkarainen, Tanja, Tenhunen, Mikko, Diaconu, Iulia, Kuhmonen, Venla, Kairemo, Kalevi, Kanerva, Anna, Airaksinen, Anu J, Hemminki, Akseli

    Published in PloS one (07-03-2012)
    “…Oncolytic adenoviruses can be engineered for better tumor selectivity, gene delivery and be armed for imaging and concentrating radionuclides into tumors for…”
    Get full text
    Journal Article
  14. 14

    Targeted Radiotherapy for Prostate Cancer with an Oncolytic Adenovirus Coding for Human Sodium Iodide Symporter by HAKKARAINEN, Tanja, RAJECKI, Maria, SARPARANTA, Mirkka, TENHUNEN, Mikko, AIRAKSINEN, Anu J, DESMOND, Renée A, KAIREMO, Kalevi, HEMMINKI, Akseli

    Published in Clinical cancer research (01-09-2009)
    “…Purpose: Oncolytic adenoviruses are promising tools for cancer therapy. Although several clinical reports have indicated both safety and promising antitumor…”
    Get full text
    Journal Article
  15. 15

    Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models by Keinänen, Outi, Fung, Kimberly, Pourat, Jacob, Jallinoja, Vilma, Vivier, Delphine, Pillarsetty, NagaVara Kishore, Airaksinen, Anu J., Lewis, Jason S., Zeglis, Brian M., Sarparanta, Mirkka

    Published in EJNMMI research (02-12-2017)
    “…Background Pretargeting-based approaches are being investigated for radioimmunoimaging and therapy applications to reduce the effective radiation burden to the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20